Uptrend Under Pressure 100
Institutional selling is building — 7 distribution days in the last 25 sessions. Severe risk · 100/100 · 7 distribution days (SPY) Oct 26 Full briefing →
View
Simple research view

REGN · Regeneron Pharmaceuticals, Inc.

$807.67 +0.33% Oct 26 close
Detected setup Cup & Handle · Setup Score 55/100

Stand aside — setup invalidated

Setup score 55, but price closes below stop $827.49 — stand aside until the condition resets.

Ask about REGN

Switch to Advanced for indicator panels, raw grades, provenance, drawing tools, and full technical tables.

$REGN

Regeneron Pharmaceuticals, Inc.

Regeneron Pharmaceuticals, Inc. is a large-cap Pharmaceuticals: Major company in the Health Technology sector with a market cap of $76B.

Health Technology Pharmaceuticals: Major stock Stage 2 · Advancing Base 3+
$807.67 latest close
Market Structure
Trend structure: downtrend
Latest event: bos (bearish)
Support 788.69–794.77 · 6 touches · strong
Support 727.88–734.12 · 4 touches · moderate
Support 775.62–781.21 · 4 touches · moderate
Support 637.80–640.82 · 3 touches · moderate
Support 767.21–771.23 · 3 touches · moderate
Verdict · setup score 55/100 · data Oct 26 close · latest session

Stand aside — setup invalidated

Setup score 55, but price closes below stop $827.49 — stand aside until the condition resets.

Recent price action · daily
$800AugSepOct$808

What would change this verdict

What needs to turn for this to become buyable — the top failing checks across the legend council:

  • Minervini 1.2 150-day MA > 200-day MA — MA150 $726.30 vs MA200 $736.04
  • Minervini 2. Quarterly EPS growth ≥ 25% — -3.3% QoQ
  • O'Neil C: Quarterly EPS acceleration ≥ 25% — -3.3% QoQ
  • O'Neil L: RS rank ≥ 80 (IBD leadership) — RS rank 77
  • Weinstein Volume expansion above average — Volume ratio 0.62x
  • Dennis S1: 20-day Donchian breakout
Minority view — the council disagrees here
  • Minervini: avoid Trend-template read: fails 150-day MA > 200-day MA.
  • O'Neil: avoid CANSLIM read: fails C: Quarterly EPS acceleration ≥ 25%.
  • Weinstein: watch Stage-analysis read: Stage 2 is present; 1 supporting checks need improvement.
62 Neutral
Legend Score · rates the stock Neutral (62/100) — held back by eps growth

Our proprietary 0-100 rating — the answer to Wall Street's black-box scores. Five pillars, each computed from real scan data, each explained below in plain English.

  • Relative Strength (25%) 78
  • Trend Template (25%) 75
  • Institutional Footprint (20%) 61
  • EPS Growth (15%) 30
  • Quality (SMR-like) (15%) 44

RS rank 77: above-average strength. Trend template 6/8: passes the uptrend screen, structure intact. Institutional score 61: mild accumulation. EPS -0% last quarter — no earnings momentum. Quality 44: weak fundamentals (sales growth 30, return on equity 41, leverage 100). Updated 2026-10-27.

Earnings

Post-earnings setup

Next earnings Monday, October 26, 2026 Report time not confirmed by the source

Deterministic evidence

REGN+0.33%
Sector proxy · XLV+0.00%
Broad market · SPY+0.71%
Same completed session window ending 2026-10-26. REGN was +0.33 points vs XLV. -0.38 points vs SPY.
CatalystUnavailable Stock reactionPositive Sector reactionWeak Opening surge— Event riskEarnings-driven

Session internals Mixed

Rule: direction and internals disagree — it met neither the strong nor the weak rule. Judged on internals, not on the size of the move.

Vs prior close+0.33% From the open-0.57% Range position54% GapNo gap
QQQ confirmationConfirming (+1.11%) SMH confirmationConfirming (+2.74%)
Price bars, sourced event fields, and benchmark math only. This can adjust displayed short-term conviction; it does not change the stored scanner score or readiness.

Ask a Legend to interpret this evidence → Commentary only — never scanner evidence or a sizing recommendation.

Price $807.67 +0.3% Oct 26 close
52W High $859.34 6.0% below high
Wks Since High 7w
Base Depth 16.0%
RS Rank 51 percentile of scan
SMA 50 $791.46
Avg Vol 687,627
Rel Vol (Oct 26) 0.62× 0.91× on up days
More stats
52W Low $575.93
Tight Wks 0
Base B3
SMA 200 $736.04
RS Line vs High -11.2%
RS Line Slope +7.5% ▲
Group Rank #13/66
ADR% 2.6%
ATR(14) $21.81 (2.7%)
Vol Pace (live) N/A
A/D Days 20A / 9D
A/D Rating A+
VDU Bars 0/10 d
Earnings in 3d
Position in 52-week range 82ndpercentile of the 52-week range
$575.93low
$859.34high

REGN Chart

Interactive price, volume, RS, RSI, and MACD charts are available after sign in.

Create a free account to load the full interactive chart for REGN.

Create Free Account

Technical Analysis Report Card

$REGN · $807.67 · as of 2026-10-26 · multi-factor read
93
/ 100
Technicals 93/100
Reference read from price & volume only — the verdict at the top of the page decides the action.

Trend · Daily / Weekly / Monthly

Daily ▬ Sideways / consolidating
Weekly ▲ Uptrend
Monthly ▲ Uptrend

Moving Averages

50-day$791.46 ↑
100-day$733.62 ↑
200-day$736.04 ↑
Bullish (50 > 200)

RSI (14)

Reading58.8 · Bullish

Bullish momentum — comfortably in buyer territory.

MACD (12/26/9)

StateBullish
Histogram+6.568

Bullish — MACD above its signal line and above zero. Histogram contracting.

Bollinger Bands (20,2)

%B / Width82% · 15.8%

Near the upper band — buyers in control.

Volume · Buyer vs Seller

Up/Down vol0.91 · Neutral
Rel volume0.62×
Pocket pivots · 10d1
5d vs 50d vol85%
Heavy vol up / down0 / 0

Balanced — up/down volume is roughly even; no clear hand. Recent volume is easing versus its baseline.

  • Pocket pivot 2 sessions ago — up-day volume beat every down day of the prior 10 sessions.

Support & Resistance

R · $813.53swing level
R · $847.00swing level
R · $859.3452-week high
Price · $807.67now
S · $779.08swing level
S · $769.57swing level
S · $737.34swing level

Fibonacci · Uptrend swing

23.6% ◄ price here$796.13
38.2%$757.03
50.0%$725.43
61.8%$693.83
78.6%$648.83

Retracement support zones measured from the recent swing low up to the high.

The verdict is free. The trade plan is Pro.
Unlock the exact entry, stop-loss, profit target, and reward-to-risk for REGN — plus the full 500+ symbol scanner and Ask-the-Legends chat.
Start your 7-day free trial →
Weekly uptrendMonthly uptrendAbove 200-day MA50/200 bullish
Want this read in a legend's voice? Ask a Legend about REGN
Generic technical analysis generated mechanically from price & volume — educational research only, not financial advice or a personalized recommendation. Levels are illustrative; confirm on your own chart. New to these terms? →
Legend Verdicts 6 methodology checks

Who would consider this setup, why it qualifies, and what blocks it — calculated from the same deterministic methodology rules used across Legend AI.
How to read the numbers: the setup score (55/100, in the verdict band) rates this trade setup. Each legend's A–D grade rates the same setup against that legend's own checklist — so a high score next to a C grade is not a contradiction. The setup can be strong without fitting that legend's style. When the council disagrees, the verdict band breaks the tie.

Council consensus: 7 of 9 legends are Watching — building, not yet a confirmed buy.
Minervini Avoid C Trend-template read: fails 150-day MA > 200-day MA.

partialRule check says AVOID (8/12 checks passed) — Trend-template read: fails 150-day MA > 200-day MA.

Passing evidence
1.1 Price > 150-day MA AND 200-day MAPrice $807.67, MA150 $726.30, MA200 $736.04
1.4 50-day MA > 150-day MA AND 200-day MAMA50 $791.46, MA150 $726.30, MA200 $736.04
Failing evidence
1.2 150-day MA > 200-day MAMA150 $726.30 vs MA200 $736.04
2. Quarterly EPS growth ≥ 25%-3.3% QoQ
8/12 checks
O'Neil Avoid D CANSLIM read: fails C: Quarterly EPS acceleration ≥ 25%.

partialRule check says AVOID (2/8 checks passed) — CANSLIM read: fails C: Quarterly EPS acceleration ≥ 25%.

Passing evidence
N: Near 52-week high or RS line new high6.0% below high | RS line new high: False
S: Base tightness (ATR% ≤ 4.5%)ATR% 2.70%
Failing evidence
C: Quarterly EPS acceleration ≥ 25%-3.3% QoQ
L: RS rank ≥ 80 (IBD leadership)RS rank 77
2/8 checks
Weinstein Watch B Stage-analysis read: Stage 2 is present; 1 supporting checks need improvement.

mediumStage 2 uptrend in progress — hold as long as price stays above the 30-week moving average.

Passing evidence
Stage 2 (Advancing phase) confirmedStage 2 (Advancing)
Price above 30-week MA (200-day proxy)Price $807.67 vs MA200 $736.04
Failing evidence
Volume expansion above averageVolume ratio 0.62x
6/7 checks
dennis Watch C Turtle read: no breakout yet. Price is pressing the 20-day high. The system waits for the print; it never anticipates.
Passing evidence
No breakdown below the 20-day channel20-day low $722.02
Volatility-unit sizing (1N ≈ 1% of equity)1N = $21.07 (2.61% of price); the Turtles size 1 unit so a 1N move ≈ 1% of equity, making the 2N stop ≈ 2% equity risk
Failing evidence
S1: 20-day Donchian breakoutNot confirmed
S2: 55-day Donchian breakoutNot confirmed
5/7 checks
zanger Watch B Zanger read: the structure is fine but the breakout quality is not there yet — wait for 150%+ volume on the break.

partialZanger would buy the Cup & Handle breakout only with 150-200% volume, never more than 5% above the breakout point, with a 2-3% stop set at entry. His edge over O'Neil is the exit plan: sell 20-30% of the position at +15-20%, then trail the rest on the 10/20-day moving average.

Passing evidence
Named Zanger pattern onlyCup & Handle
Not extended (≤5% above the breakout point)Measured as passing
Failing evidence
Breakout volume 1.5-2.0x averageData unavailable
5/6 checks
zweig Watch D Zweig read: part of his screen passes but not all: EPS growth above the market (≥15% QoQ); Insider buying — wait for the full growth screen before treating this as a Zweig setup.
Passing evidence
Reasonable price for the growth (P/E ≤ 35)Trailing P/E 19.5x — no PEG or forward P/E stored
Price strength (RS ≥ 70)RS score 77 — Zweig buys strength, not bargains
Failing evidence
EPS growth above the market (≥15% QoQ)-3.3% QoQ — Zweig wants growth above the S&P average
Insider buyingNo insider buying flagged
4/8 checks
Livermore Watch B Pivotal-point read: constructive evidence is present, but volume vs average is unresolved.
Passing evidence
Price$807.67
Relative strengthRS 77
Failing evidence
Volume vs average0.62x
Pivotal point cleared on expanding volumeNot confirmed
4/6 checks
Darvas Watch B Box-theory read: constructive evidence is present, but volume vs average is unresolved.

mediumBuilding the top of the box (6.0% from 52W high) — watch for a box breakout with volume expansion.

Passing evidence
Price$807.67
Relative strengthRS 77
Failing evidence
Volume vs average0.62x
Box top broken on heavy volumeNot confirmed
4/6 checks
Wyckoff Watch B Supply-and-demand read: constructive evidence is present, but volume vs average is unresolved.
Passing evidence
Price$807.67
Relative strengthRS 77
Failing evidence
Volume vs average0.62x
Sign of Strength confirmed on expanding volumePrice hasn't cleared the pivot yet — confirmation pending
4/6 checks
Base & Breakout
Breakout follow-through

No active breakout tracked — Legend AI monitors daily for pivot-point breaks. What's a breakout?

RS Line vs SPY 52-week relative strength · blue = RS line · dashed = MA50 · dot = NH ▲ Rising
124RS Line (52W)
Accumulation / Distribution last 65 sessions · green = acc on high vol · red = dist on high vol Net +9 A+
A: 19 D: 10 Net: +965 sessions
Minervini · Grade Card
Fundamentals & leadership quality — Minervini’s published criteria · 3/7 met
C 3/7 criteria
Separate score from the Minervini Trend Template (7/8): the Trend Template grades the price structure, this grades the company & leadership (earnings, sales, margins, RS rank). A stock can ride a clean trend while its fundamentals lag, so the two often differ by design — they are not the same checklist.
✗ EPS acceleration ≥25% QoQ -3%
✗ Revenue growth ≥20% YoY +1%
✓ Gross margin ≥30% 87%
✗ ROE ≥17% 15%
✗ RS rating ≥80 (leadership) 77
✓ Stage 2 uptrend (Weinstein) Stage 2
✓ Within 25% of 52W high -6.0%

Method Playbook

Trade it like Zanger EXACT LEVELS · PRO
Zanger B · Watch — The deterministic methodology check is Watch; wait for the failing or incomplete criteria to improve before the trigger can qualify.
Pivot
Pro level
Published-method rule: Use the breakout point of a named pattern (flat base, bull flag, ascending triangle, cup and handle, double bottom, symmetrical triangle).
Evidence: Canonical setup geometry is available with Pro.
Entry trigger
Pro level
Published-method rule: Buy the breakout day on 150-200% of average volume. Never pay more than 5% above the breakout point.
Evidence: Canonical setup geometry is available with Pro.
Initial stop
Pro level
Published-method rule: Set the stop 2-3% below entry and sell on bad price action before it is even hit.
Evidence: Canonical setup geometry is available with Pro.
Trail
Rule-based
Published-method rule: Sell 20-30% of the position at +15-20% from the breakout, then trail the rest on the 10/20-day moving average.
Evidence: Planned management rule; no stored stop or broker order is changed automatically.
Exit / invalidation
Pro level
Published-method rule: Out on a break of the 10/20-day MA, a failed breakout back below the pivot, or a reversal pattern — winners are held, laggards are sold fast.
Evidence: Canonical setup geometry is available with Pro.
Deterministic educational plan, not a recommendation. No order or stop is changed automatically. Method and sources →

Pattern Analysis

Cup & Handle ⚠ 3rd-stage base ⚠ Not actionable yet
55 setup score
RS Score 77
Trend template 7/8
CANSLIM 61.9* (C)
27.1% cup depth 3.5% handle
  • Cup 27.1% deep from a $811.24 left rim to a $591.52 low
  • Rims 5.9% apart (ideal, within 10%)
  • Handle pulled back 3.5% over 2 bars from $809.49 to $780.83
  • Handle sits in the upper half of the cup
  • Rounded U-shaped bottom
  • Pivot $859.34 fixed at the handle high
  • No close above the pivot yet
  • Volume dried up in the handle
Raw detector evidence · confidence is a heuristic match score, not a probability depth=27.1%, handle_pb=3.5%, lips_diff=5.9%, upper_half=yes, u_shape=yes, near_pivot=no, orderly=yes | Moderate trend (6/8) | Good RS (77) | High-confidence pattern (82%) | Stage 2 | Readiness 45/100 (early) | CANSLIM 61.9 (C) | ⚠ 3rd-stage base; Not actionable yet setup_key=cup_handle|2026-06-02|2026-09-03|859.34 · cup_handle/2026-10-03 anchors={"bottom": {"bar": 108, "bars_ago": 101, "date": "2026-06-02", "price": 591.52}, "breakout": null, "handle_high": {"bar": 202, "bars_ago": 7, "date": "2026-10-15", "price": 809.49}, "handle_low": {"bar": 204, "bars_ago": 5, "date": "2026-10-19", "price": 780.83}, "left_lip": {"bar": 11, "bars_ago": 198, "date": "2026-01-12", "price": 811.2405}, "right_lip": {"bar": 173, "bars_ago": 36, "date": "2026-09-03", "price": 859.34}}
Why This Setup? D+W Confluence
cup handle Cup & Handle · schematic

depth=27.1%, handle_pb=3.5%, lips_diff=5.9%, upper_half=yes, u_shape=yes, near_pivot=no, orderly=yes | Moderate trend (6/8) | Good RS (77) | High-confidence pattern (82%) | Stage 2 | Readiness 45/100 (early) | CANSLIM 61.9 (C) | ⚠ 3rd-stage base; Not actionable yet

Pocket Pivot ⚠ 3rd-stage base ⚠ Not actionable yet
55 setup score
RS Score 77
Trend template 7/8
CANSLIM 63.1* (C)
volume ratio: 1.3 near moving avg: ✓ upper close: ✓ shooting star: ✗ price past buy range: ✗ vol beats down: ✓ bars since signal: 2 signal close: 819.09 validation reason: valid pocket-pivot multi tf evaluated: ✓ multi tf reason: weekly trend template 5/8 confirmed + no fresh 13-week low
Why This Setup? D+W Confluence
Pocket Pivot · schematic

Up vol 852,594 vs max down vol 655,842 (near MA), upper_close=yes, bars_ago=2 | Moderate trend (6/8) | Good RS (77) | Moderate pattern (65%) | Stage 2 | Readiness 51/100 (early) | CANSLIM 63.1 (C) | ⚠ 3rd-stage base; Not actionable yet

The Universal Edge Check · context only

What the setup still has going for it, recorded for later. The verdict above stands — these principles do not overrule it.

4/7 universals met
  • A relative-strength leader — not met RS rank 51 — laggard
  • Clear of earnings — not met in 3 days — event risk
  • Volume confirms — partly met 0.6× average — light
  • Asymmetric reward — met Met — levels are a Pro detail
  • In a confirmed uptrend — met Stage 2 · Trend template 7/8
  • Not chasing (in range) — met Met — levels are a Pro detail
  • Risk is defined — met Met — levels are a Pro detail
Why these seven? → The Universal Edge

Minervini Trend Template

7/8

Grades the price structure — moving-average stacking, distance from the 52-week high/low, and relative strength above the ≥70 uptrend bar. This is the technical trend check; the company's fundamentals and ≥80 RS leadership are scored separately in the Grade Card.

Price above SMA 150 & 200 $807.67 vs SMA150 $726.30 / SMA200 $736.04
SMA 150 above SMA 200 SMA150 $726.30 vs SMA200 $736.04
SMA 200 trending up Slope +0.06 over 20 days
SMA 50 above SMA 150 & 200 SMA50 $791.46
Price above SMA 50 $807.67 vs SMA50 $791.46
30%+ above 52-week low +40.2% from $575.93
Within 25% of 52-week high -6.0% from $859.34
RS score above 70 RS 77

Fundamentals

52W Range
82%
Mkt Cap SEC
75.9B
EPS QoQ
-3%
Rev YoY
+1%
ROE
15%
Gross Margin
87%
D/E
0.09
EPS TTM
$41.48
P/E TTM
19.5x
Float
94M
Insider
No Buy

Company

Company profile
Regeneron Pharmaceuticals, Inc.
REGN · NASDAQ · Health Technology · Pharmaceuticals: Major
O'Neil · Grade Card
CANSLIM — current EPS, annual EPS, new highs, supply, leader RS, inst. sponsorship, market
C 61.9* CANSLIM * disqualified on C, M
C · Curr. EPS
50
A · Annual EPS
66
N · New Highs
100
S · Supply/Demand
80
L · Leader RS
77
I · Inst. Spons.
50
M · Market
30

Weekly Context

Multi-timeframe signals from weekly bars
W. Trend
5/8
W. RS
66
W. Support
$591.52
W. Resist
$859.34
W. Patterns
Cup & Handle
Weekly Structure

Scan History

20× streak
Oct 23: 68 (Pocket Pivot)Oct 23: 68 (Darvas Box)Oct 26: 55 (Cup & Handle)Oct 27: 55 (Cup & Handle)55
Oct 27
Cup & Handle ✓ Gate
55
Oct 26
Cup & Handle ✓ Gate
55 0.0%
Oct 23
Darvas Box ✓ Gate
68 +0.3%
Oct 23
Pocket Pivot ✓ Gate
68 +0.3%

Latest News

Headlines for REGN
Loading headlines…

Get the full picture on REGN

Pro members see entry/stop/target levels, R:R ratios, intraday alerts, and every setup detected across 500+ symbols daily.

Start 7-Day Free Trial